Geovax Labs Inc

General ticker "GOVX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $15.9M

Geovax Labs Inc does not follow the US Stock Market performance with the rate: -3.5%.

Estimated limits based on current volatility of 3.4%: low 2.17$, high 2.32$

Factors to consider:

  • Current price 28.6% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [3.17$, 9.20$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.78$, 7.82$]

Financial Metrics affecting the GOVX estimates:

  • Negative: Non-GAAP EPS, $ of -23.95 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -64.21 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
  • Negative: Industry earnings per price (median), % of -26.04 <= 1.31

Similar symbols

Short-term GOVX quotes

Long-term GOVX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.39MM $0.08MM $0.00MM
Operating Expenses $19.13MM $14.11MM $26.74MM
Operating Income $-18.75MM $-14.03MM $-26.74MM
Non-Operating Income $0.18MM $0.01MM $0.78MM
Interest Expense $0.00MM $0.00MM $0.00MM
R&D Expense $15.55MM $9.12MM $20.72MM
Income(Loss) $-18.57MM $-14.02MM $-25.97MM
Profit(Loss) $-18.57MM $-14.02MM $-25.97MM
Stockholders Equity $4.36MM $26.60MM $5.76MM
Inventory $0.05MM $0.00MM $0.00MM
Assets $11.80MM $31.35MM $9.28MM
Operating Cash Flow $-11.20MM $-19.03MM $-25.17MM
Capital expenditure $0.05MM $0.13MM $0.05MM
Investing Cash Flow $-0.05MM $-0.13MM $-0.05MM
Financing Cash Flow $12.78MM $35.35MM $4.06MM
Earnings Per Share* $-7.30 $-5.52 $-10.22

* EPS are Split Adjusted, recent splits may be reflected with a delay.